Letters to the Editor

Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy

University College London Hospitals, London
University College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, London
University College London Hospitals, London
University College London Hospitals, London
Molecular Haematology, Health Services Laboratories, London WC1H 9AX
University College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, London
University College London Hospitals, London
University College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, London, UK; Molecular Haematology, Health Services Laboratories, London WC1H 9AX
University College London (UCL) Cancer Institute, UCL, London, UK; CRUK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL
University College London Hospitals, London, UK; University College London (UCL) Cancer Institute, UCL, London
Haematologica Early view Apr 30, 2025 https://doi.org/10.3324/haematol.2025.287341